Research Paper Volume 13, Issue 24 pp 25778—25798
PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis
Figure 3. Survival analysis for WEE family kinases. The overall survival and disease free survival between the high and low expression groups of WEE1 (A, B) and WEE2 (C, D) displayed no significant difference. However, the high expression group of PKMYT1 tended to have lower overall survival (E) and disease free survival (F) in ccRCC.